Urological Conditions

Brief Description and Purpose

The genitourinary system contains a particularly sensitive anatomical and functional infrastructure: mucous membranes with high metabolic demands, vascular networks that are directly affected by systemic diseases, and tissues that, in cases of radiotherapy or chronic inflammation, undergo permanent biological changes that are difficult to reverse through conventional means.

Hyperbaric oxygen chamber therapy is incorporated into urology as a complementary intervention with a clear biological rationale: by restoring oxygenation in tissues with vascular insufficiency, reducing chronic inflammation, and activating regenerative mechanisms, it helps urological tissue restore functions that have been disrupted by disease, radiation, or surgery. Always alongside conventional urological care, never as a substitute for it.

Key Characteristics of the Treatment

In the urological field, hyperbaric oxygen chamber therapy utilizes four key properties. First, it directly improves oxygenation of tissues with reduced vascular supply, whether due to radiation injury or chronic inflammation.

It then induces neoangiogenesis through VEGF for long-term restoration of the vascular infrastructure. At the same time, it exerts a strong anti-inflammatory effect that reduces chronic inflammation of mucous membranes. Finally, it activates healing mechanisms in tissues that have become biologically inactive due to ischemia.

The synergy of these four mechanisms makes the method particularly suitable for urological conditions characterized by chronicity and resistance to conventional treatments.

Scientific Basis

In the urological field, the strongest scientific evidence concerns radiation-induced hemorrhagic cystitis, an approved indication by the UHMS, with response rates of 70–90% reported in the literature.

For other urological applications, such as chronic prostatitis, male infertility, and postoperative complications, the scientific evidence is steadily growing, with emerging but promising clinical data.

The common scientific rationale is improved tissue oxygenation: in each urological condition within this category, ischemia or hypoxia is a critical pathophysiological factor, and addressing it has demonstrated clinical benefits.